Pharmacological Interference With Protein-protein Interactions of Akinase Anchoring Proteins as a Strategy for the Treatment of Disease

Curr Drug Targets. 2016;17(10):1147-71. doi: 10.2174/1389450116666150416114247.

Abstract

A-kinase anchoring proteins (AKAPs) control the localization of cAMP-dependent protein kinase A (PKA) by tethering PKA to distinct cellular compartments. Through additional direct proteinprotein interactions with PKA substrates and other signaling molecules they form multi-protein complexes. Thereby, AKAPs regulate the access of PKA to its substrates in a temporal and spatial manner as well as the local crosstalk of cAMP/PKA with other signaling pathways. Due to the increasing information on their molecular functioning and three-dimensional structures, and their emerging roles in the development of diseases, AKAPs move into the focus as potential drug targets. Targeting AKAP dependent protein-protein interactions for interference with local signal processing inside cells potentially allows for the development of therapeutics with high selectivity and fewer side effects.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • A Kinase Anchor Proteins / chemistry
  • A Kinase Anchor Proteins / metabolism*
  • Animals
  • Cyclic AMP-Dependent Protein Kinases / metabolism*
  • Drug Design
  • Humans
  • Molecular Targeted Therapy*
  • Protein Conformation
  • Signal Transduction / drug effects

Substances

  • A Kinase Anchor Proteins
  • Cyclic AMP-Dependent Protein Kinases